Consolidated Statement of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities
Net income	$ 144,784	$ 170,400
Add (deduct) adjustments to reconcile net income to net cash flows from operating activities
Depreciation, amortization and accretion	593,410	439,391
Bad debts expense	52,184	51,293
Stock-based compensation expense	11,143	15,924
Deferred income taxes, net	(38,515)	52,865
Equity in earnings of unconsolidated entities	(99,797)	(71,584)
Distributions from unconsolidated entities	49,612	45,211
Loss on asset disposals, net	16,153	15,967
(Gain) loss on sale of business and other exit costs, net	(243,627)	(4,148)
(Gain) loss on investments	(18,527)	3,728
Noncash interest expense	792	1,331
Other operating activities	590	863
Changes in assets and liabilities from operations
Accounts receivable	(214,114)	(67,302)
Inventory	13,236	(69,423)
Accounts payable - trade	32,202	(28,902)
Accounts payable - affiliate	345	(4,785)
Customer deposits and deferred revenues	22,538	26,687
Accrued taxes	45,780	99,556
Accrued interest	9,385	9,508
Other assets and liabilities	(81,341)	(77,821)
Cash flows from operating activities	296,233	608,759
Cash flows from investing activities
Cash used for additions to property, plant and equipment	(522,180)	(611,431)
Cash paid for licenses	(16,540)	(57,957)
Cash received from divestitures	484,300	49,932
Cash paid for investments		(45,000)
Cash received for investments	65,000	50,000
Other investing activities	583	(5,030)
Cash flows from investing activities	11,163	(619,486)
Cash flows from financing activities
Repayment of long-term debt	(393)	(343)
Common shares reissued for benefit plans, net of tax payments	2,840	(2,299)
Common shares repurchased	(18,544)
Dividends paid	(482,270)
Distributions to noncontrolling interests	(3,447)	(1,491)
Other financing activities	(839)	284
Cash flows from financing activities	(502,653)	(3,849)
Net decrease in cash and cash equivalents	(195,257)	(14,576)
Cash and cash equivalents
Beginning of period	378,358	424,155
End of period	$ 183,101	$ 409,579